Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masashi Bando

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Modern Rheumatology|August 21, 2023
Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update - secondary publicationKen-Ei Sada, Kenji Nagasaka, Shinya Kaname, et al.
Respirology (Carlton, Vic.)|March 22, 2006
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosisAkihito Yokoyama, Keiichi Kondo, Masamitsu Nakajima, et al.
Respiratory Investigation|November 30, 2024
Severity and prognosis of COVID-19 complicated by autoimmune pulmonary alveolar proteinosisToru Arai, Yoshikazu Inoue, Keiichi Akasaka, et al.
Respiratory Investigation|July 13, 2023
Carboplatin and weekly paclitaxel in combination with bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic interstitial pneumonias: A feasibility studyMiwako Omori, Yuji Minegishi, Hironori Uruga, et al.
Respiratory Investigation|May 27, 2025
The hygiene environment during childhood may affect susceptibility to sarcoidosis: A case-control study of environmental risk factorsMichiru Sawahata, Naoto Arai, Ryohei Kamei, et al.
Plos One|November 10, 2016
Clinical Course and Changes in High-Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis without HoneycombingHiroyoshi Yamauchi, Masashi Bando, Tomohisa Baba, et al.
Modern Rheumatology|June 6, 2023
Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteriaKen-Ei Sada, Kenji Nagasaka, Shinya Kaname, et al.
Modern Rheumatology|January 30, 2023
Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody-associated vasculitisKen-Ei Sada, Shinya Kaname, Tomoaki Higuchi, et al.
Respirology (Carlton, Vic.)|August 9, 2017
Disease severity staging system for idiopathic pulmonary fibrosis in JapanYasuhiro Kondoh, Hiroyuki Taniguchi, Kensuke Kataoka, et al.
The European Respiratory Journal|December 16, 2014
Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisTakashi Ogura, Hiroyuki Taniguchi, Arata Azuma, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Modern Rheumatology|August 21, 2023
Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update - secondary publicationKen-Ei Sada, Kenji Nagasaka, Shinya Kaname, et al.
Respirology (Carlton, Vic.)|March 22, 2006
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosisAkihito Yokoyama, Keiichi Kondo, Masamitsu Nakajima, et al.
Respiratory Investigation|November 30, 2024
Severity and prognosis of COVID-19 complicated by autoimmune pulmonary alveolar proteinosisToru Arai, Yoshikazu Inoue, Keiichi Akasaka, et al.
Respiratory Investigation|July 13, 2023
Carboplatin and weekly paclitaxel in combination with bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic interstitial pneumonias: A feasibility studyMiwako Omori, Yuji Minegishi, Hironori Uruga, et al.
Respiratory Investigation|May 27, 2025
The hygiene environment during childhood may affect susceptibility to sarcoidosis: A case-control study of environmental risk factorsMichiru Sawahata, Naoto Arai, Ryohei Kamei, et al.
Plos One|November 10, 2016
Clinical Course and Changes in High-Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis without HoneycombingHiroyoshi Yamauchi, Masashi Bando, Tomohisa Baba, et al.
Modern Rheumatology|June 6, 2023
Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteriaKen-Ei Sada, Kenji Nagasaka, Shinya Kaname, et al.
Modern Rheumatology|January 30, 2023
Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody-associated vasculitisKen-Ei Sada, Shinya Kaname, Tomoaki Higuchi, et al.
Respirology (Carlton, Vic.)|August 9, 2017
Disease severity staging system for idiopathic pulmonary fibrosis in JapanYasuhiro Kondoh, Hiroyuki Taniguchi, Kensuke Kataoka, et al.
The European Respiratory Journal|December 16, 2014
Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisTakashi Ogura, Hiroyuki Taniguchi, Arata Azuma, et al.
Pageof 14